A U.S. regulator reportedly plans to unveil a faster approach to approving custom gene-editing treatments for rare diseases.
Following the RBI instructions, top banks in India, including State Bank of India (SBI), Punjab National Bank (PNB), Canara ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback